跳至主要内容
临床试验/KCT0003899
KCT0003899招募中未知

A randomized controlled study of ATN DBS epilepsy treatment to assess the therapeutic superiority between cyclic and continuous mode in Korean epilepsy patients(ATTACK study)

Samsung Medical Center0 个研究点目标入组 40 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
19(Year) 至 65(Year)(—)
性别
All

入选标准

  • A _ Patients aged 19 years and under 65
  • B _ Patients who have previously been diagnosed with drug-resistant epilepsy
  • C _ Patients with more than two seizures a month, despite two or more anti-interesting medications.
  • D _ Video brainwaves for regionalization of epilepsy and preoperational examinations (MRI, FDG PET, etc.) offer conflicting results without providing an accurate focus
  • E _ Patients who are not adapted to surgical treatment due to anticipated neurological side effects or multiple epilepsy focal lesions

排除标准

  • A _ Patient is unable to cooperate due to a confusion in the conscious state (below stupor)
  • B _ Pseudoseizure is performed

研究者

相似试验